Stark Wipes Out $2.5 Billion Verdict in Hep C Drug Patent Case


A Delaware federal judge on Feb. 16 overturned a massive $2.5 billion jury verdict against Gilead Sciences Inc., finding that a patent held by a unit of Merck & Co. Inc. was too broad to be valid.



from Biotech News